乐观
$56.20
情景价格
$63.520
+1.264 (+1.99%)收盘时
Establishment Labs Holdings Inc. is Costa Rica-based medical technology and aesthetics company that is focused on women's health reconstruction market. The Company is engaged in the designing, developing, manufacturing and marketing of product portfolio consisting of silicone-filled breast and body shaping implants. The main activities are conducted at two manufacturing facilities in Costa Rica including Motiva Implants brand sold in over 80 countries globally through a combination of distributors and direct sales to customers.
Establishment Labs Holdings Inc is currently a hold. The stock is trading at $59.18, with a forward P/E ratio of 204.08, indicating high valuation concerns. Despite a strong gross margin of 70.64% in Q2 2026 and a positive analyst price target of $117, the stock has seen a 14.60% decline over the past 20 days and significant insider selling, which raises caution. The main risk is the negative earnings trend, with EPS reported at -0.39 for Q2 2026, suggesting ongoing profitability challenges.
Citi
$92
2026-08-13
Citi
2026-08-13
目标价
$92
Canaccord
$105
2026-08-07
Canaccord
2026-08-07
目标价
$105
Mizuho
$105
2026-07-15
Mizuho
2026-07-15
目标价
$105
Citi
$92
2026-07-08
Citi
2026-07-08
目标价
$92
BTIG
$90
2026-05-07
BTIG
2026-05-07
目标价
$90
情景价格取自当年最后一个月度预测区间。概率为固定的模型权重(25 / 50 / 25),不构成保证。

Latest Wall Street Rating Updates

Establishment Labs Receives FDA Approval for Expanded Breast Implant Range

Establishment Labs Presents New Clinical Data on Breast Tissue Preservation

GLP-1 Drugs Boost Demand for Breast Augmentation

Global Medical Aesthetics Market Poised for Significant Growth
Establishment Labs Holdings Inc. is Costa Rica-based medical technology and aesthetics company that is focused on women's health reconstruction market. The Company is engaged in the designing, developing, manufacturing and marketing of product portfolio consisting of silicone-filled breast and body shaping implants. The main activities are conducted at two manufacturing facilities in Costa Rica including Motiva Implants brand sold in over 80 countries globally through a combination of distributors and direct sales to customers. It operates in the Healthcare sector (ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUP industry).
Establishment Labs Holdings Inc is currently a hold. The stock is trading at $59.18, with a forward P/E ratio of 204.08, indicating high valuation concerns. Despite a strong gross margin of 70.64% in Q2 2026 and a positive analyst price target of $117, the stock has seen a 14.60% decline over the past 20 days and significant insider selling, which raises caution. The main risk is the negative earnings trend, with EPS reported at -0.39 for Q2 2026, suggesting ongoing profitability challenges.
3 analysts cover ESTA: 3 rate it Buy, 0 Hold and 0 Sell. The average price target is 82.88.
暂无帖子
注册或登录后参与讨论本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。